Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CTLT |
---|---|---|
09:32 ET | 6984 | 59.205 |
09:33 ET | 2519 | 59.28 |
09:35 ET | 3500 | 59.35 |
09:37 ET | 2800 | 59.315 |
09:39 ET | 1391 | 59.33 |
09:42 ET | 2426 | 59.36 |
09:44 ET | 3808 | 59.33 |
09:46 ET | 2137 | 59.3 |
09:48 ET | 28500 | 59.315 |
09:50 ET | 3510 | 59.36 |
09:51 ET | 700 | 59.355 |
09:53 ET | 1545 | 59.345 |
09:55 ET | 9118 | 59.355 |
09:57 ET | 2000 | 59.37 |
10:00 ET | 1166 | 59.39 |
10:02 ET | 4983 | 59.41 |
10:04 ET | 2994 | 59.43 |
10:06 ET | 4951 | 59.45 |
10:08 ET | 928 | 59.41 |
10:09 ET | 3111 | 59.385 |
10:11 ET | 15840 | 59.425 |
10:13 ET | 3370 | 59.425 |
10:15 ET | 12242 | 59.4 |
10:18 ET | 2600 | 59.4 |
10:20 ET | 1200 | 59.385 |
10:22 ET | 2282 | 59.38 |
10:24 ET | 433 | 59.39 |
10:26 ET | 29401 | 59.43 |
10:27 ET | 15950 | 59.445 |
10:29 ET | 4987 | 59.45 |
10:31 ET | 1873 | 59.465 |
10:33 ET | 2612 | 59.46 |
10:36 ET | 1504 | 59.485 |
10:38 ET | 500 | 59.49 |
10:40 ET | 488 | 59.495 |
10:42 ET | 3291 | 59.47 |
10:44 ET | 300 | 59.49 |
10:45 ET | 1899 | 59.495 |
10:47 ET | 400 | 59.485 |
10:49 ET | 600 | 59.485 |
10:51 ET | 1600 | 59.485 |
10:54 ET | 1148 | 59.475 |
10:56 ET | 1897 | 59.5 |
10:58 ET | 2526 | 59.515 |
11:00 ET | 400 | 59.505 |
11:02 ET | 1400 | 59.505 |
11:03 ET | 1689 | 59.505 |
11:05 ET | 400 | 59.505 |
11:07 ET | 1255 | 59.49 |
11:09 ET | 2018 | 59.5 |
11:12 ET | 600 | 59.505 |
11:14 ET | 800 | 59.505 |
11:16 ET | 2002 | 59.485 |
11:18 ET | 200 | 59.485 |
11:20 ET | 700 | 59.485 |
11:21 ET | 7029 | 59.465 |
11:23 ET | 1159 | 59.465 |
11:25 ET | 800 | 59.47 |
11:27 ET | 600 | 59.475 |
11:30 ET | 1139 | 59.49 |
11:32 ET | 3003 | 59.47 |
11:34 ET | 300 | 59.47 |
11:36 ET | 400 | 59.47 |
11:38 ET | 1200 | 59.475 |
11:39 ET | 1000 | 59.475 |
11:41 ET | 5351 | 59.49 |
11:43 ET | 3636 | 59.48 |
11:45 ET | 1391 | 59.495 |
11:48 ET | 620 | 59.485 |
11:50 ET | 379 | 59.485 |
11:52 ET | 1431 | 59.48 |
11:54 ET | 400 | 59.485 |
11:56 ET | 500 | 59.49 |
11:57 ET | 1349 | 59.485 |
11:59 ET | 3606 | 59.45 |
12:01 ET | 200 | 59.455 |
12:03 ET | 1020 | 59.4525 |
12:06 ET | 100 | 59.45 |
12:08 ET | 976 | 59.45 |
12:10 ET | 800 | 59.445 |
12:12 ET | 700 | 59.445 |
12:14 ET | 933 | 59.46 |
12:15 ET | 1350 | 59.445 |
12:17 ET | 1000 | 59.44 |
12:19 ET | 601 | 59.42 |
12:21 ET | 700 | 59.41 |
12:24 ET | 500 | 59.41 |
12:26 ET | 600 | 59.41 |
12:28 ET | 684 | 59.42 |
12:30 ET | 2000 | 59.395 |
12:32 ET | 900 | 59.385 |
12:33 ET | 1459 | 59.395 |
12:35 ET | 1627 | 59.41 |
12:37 ET | 1100 | 59.43 |
12:39 ET | 1909 | 59.425 |
12:42 ET | 200 | 59.425 |
12:44 ET | 939 | 59.425 |
12:46 ET | 100 | 59.425 |
12:48 ET | 3937 | 59.435 |
12:50 ET | 2300 | 59.42 |
12:51 ET | 300 | 59.42 |
12:53 ET | 1250 | 59.42 |
12:55 ET | 1009 | 59.42 |
12:57 ET | 1600 | 59.405 |
01:00 ET | 3000 | 59.4 |
01:02 ET | 7942 | 59.36 |
01:04 ET | 1330 | 59.37 |
01:06 ET | 1124 | 59.4 |
01:08 ET | 180 | 59.4 |
01:09 ET | 2200 | 59.355 |
01:11 ET | 700 | 59.36 |
01:13 ET | 6802 | 59.325 |
01:15 ET | 1391 | 59.36 |
01:18 ET | 500 | 59.36 |
01:20 ET | 1519 | 59.33 |
01:22 ET | 1300 | 59.34 |
01:24 ET | 2583 | 59.36 |
01:26 ET | 1564 | 59.35 |
01:27 ET | 1160 | 59.345 |
01:29 ET | 2305 | 59.3425 |
01:31 ET | 1400 | 59.32 |
01:33 ET | 1868 | 59.34 |
01:36 ET | 4551 | 59.3 |
01:38 ET | 11350 | 59.3 |
01:40 ET | 2958 | 59.3 |
01:42 ET | 500 | 59.31 |
01:44 ET | 1549 | 59.31 |
01:45 ET | 700 | 59.32 |
01:47 ET | 4086 | 59.31 |
01:49 ET | 313 | 59.325 |
01:51 ET | 1658 | 59.32 |
01:54 ET | 3943 | 59.3 |
01:56 ET | 2478 | 59.34 |
01:58 ET | 1078 | 59.33 |
02:00 ET | 1158 | 59.33 |
02:02 ET | 1377 | 59.33 |
02:03 ET | 2297 | 59.35 |
02:07 ET | 3255 | 59.325 |
02:09 ET | 1798 | 59.325 |
02:12 ET | 200 | 59.325 |
02:14 ET | 2374 | 59.35 |
02:16 ET | 1899 | 59.365 |
02:18 ET | 3611 | 59.34 |
02:20 ET | 1037 | 59.335 |
02:21 ET | 100 | 59.335 |
02:23 ET | 1208 | 59.345 |
02:25 ET | 2694 | 59.335 |
02:27 ET | 1352 | 59.32 |
02:30 ET | 1112 | 59.32 |
02:32 ET | 7710 | 59.295 |
02:34 ET | 7100 | 59.3 |
02:36 ET | 2037 | 59.32 |
02:38 ET | 700 | 59.31 |
02:39 ET | 1841 | 59.315 |
02:41 ET | 2802 | 59.31 |
02:43 ET | 300 | 59.315 |
02:45 ET | 17272 | 59.3 |
02:48 ET | 61838 | 59.31 |
02:50 ET | 1155 | 59.325 |
02:52 ET | 2377 | 59.34 |
02:54 ET | 5595 | 59.33 |
02:56 ET | 400 | 59.33 |
02:57 ET | 2817 | 59.31 |
02:59 ET | 15077 | 59.3 |
03:01 ET | 3386 | 59.32 |
03:03 ET | 2242 | 59.32 |
03:06 ET | 2230 | 59.31 |
03:08 ET | 10324 | 59.31 |
03:10 ET | 300 | 59.305 |
03:12 ET | 2253 | 59.3175 |
03:14 ET | 2462 | 59.305 |
03:15 ET | 899 | 59.3 |
03:17 ET | 719 | 59.3 |
03:19 ET | 400 | 59.3 |
03:21 ET | 907 | 59.3 |
03:24 ET | 800 | 59.3 |
03:26 ET | 4989 | 59.295 |
03:28 ET | 6911 | 59.291 |
03:30 ET | 984 | 59.295 |
03:32 ET | 5658 | 59.25 |
03:33 ET | 5808 | 59.26 |
03:35 ET | 6042 | 59.26 |
03:37 ET | 6660 | 59.26 |
03:39 ET | 4250 | 59.251 |
03:42 ET | 7581 | 59.23 |
03:44 ET | 4176 | 59.24 |
03:46 ET | 1883 | 59.235 |
03:48 ET | 1987 | 59.24 |
03:50 ET | 6435 | 59.255 |
03:51 ET | 6573 | 59.235 |
03:53 ET | 2898 | 59.235 |
03:55 ET | 12518 | 59.17 |
03:57 ET | 18498 | 59.105 |
04:00 ET | 261793 | 59.15 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Catalent Inc | 10.8B | -26.1x | --- |
Jazz Pharmaceuticals PLC | 7.9B | 18.0x | -3.53% |
Perrigo Company PLC | 3.6B | -25.0x | --- |
Royalty Pharma PLC | 15.3B | 10.1x | +1.83% |
Organon & Co | 4.0B | 3.1x | -14.04% |
Amneal Pharmaceuticals Inc | 2.9B | -13.2x | --- |
Catalent, Inc. is engaged in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. The Company’s Biologics segment provides formulation, development, and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells (iPSCs); oncolytic viruses, and vaccines. It also provides formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges, and analytical development and testing services for large molecules. The Company’s Pharma and Consumer Health segment comprises capabilities for oral solid doses forms, softgels, Zydis fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms. It also provides formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms, and clinical trial development and supply services.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.8B |
---|---|
Revenue (TTM) | $4.4B |
Shares Outstanding | 181.5M |
Catalent Inc does not pay a dividend. | |
Beta | 1.14 |
EPS | $-2.27 |
Book Value | $19.91 |
P/E Ratio | -26.1x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 139.7x |
Operating Margin | -2.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.